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early disease detection is a logical, imperative 
goal  necessary  to  improve  dramatically  the 
patient's odds for successful treatment strategies, 
survival  and  overall  increase  the  quality  of  life. 
Given  the  continuous  increase  in  health  care 
cost mostly due to therapy focused on end stage 
sequelae  of  diseases  rather  than  prevention  and 
early detection, it has become increasingly clear 
that existing methods are limited and falling short 
of  these  goals.  Therefore,  there  is  urgent  need 
to develop new prognostic and diagnostic assays 
that  can  detect  initial  stages  of  disease,  predict 
accurately  high  and  low  risk  patients  as  well  as 
early patient response to therapy. The increased 
knowledge of microvesicle biology and the ability of 
microvesicles to enrich tissue-specific biomarkers, 
both in normal and pathological conditions suggest 
that they may provide a valuable avenue to identify 
diagnostic  signatures,  develop  new  diagnostic 
assays and help guide therapeutic approaches.
Microvesicle  formation  is  part  of  constitutive 
biological  processes,  such  as  turnover  of 
intracellular  and  surface  membranes  during 
endocytosis  and  exocytosis,  and  normal  cellular 
response  to  complement  attack.  Microvesicles 
are found in significant amounts in plasma, urine, 
cerebrospinal  fluid  and  broncho-alveolar  lavage 
fluid.  Fragile  molecules  such  as  RNA  molecules 
show  resistance  to  degradation  by  RNAases  in 
body  fluids  when  packaged  within  microvesicles. 
For  years  identified  as  useless  cellular  debris, 
recent  data  seem  to  challenge  the  accepted 
dogma  proposing  a  novel  role  for  microvesicles, 
as conveyors of information among cells, tissues 
and  even  organs  through  horizontal  transfer  of 
proteins, lipids, and nucleic acids. As microvesicles 
are gaining increasing attention in the basic science 
circles  as  an  alternative  means  of  intercellular 
communication, they might also offer a novel way 
to  think  about  disease  detection  and  treatment. 
The  variety  of  nucleic  acids,  proteins  and  lipids 
present  in  microvesicles  has  the  potential  to 
yield  signature  molecular  patterns  informative 
of the state of the human physiology or disease 
condition. Indeed, it has been recently shown that 
certain tumors shed microvesicles, which are rich 
in  signaling  molecules,  second  messengers,  and 
genetic material that together constitute a unique, 
specific, and readily identifiable signature.
Subsequently,  microvesicles  have  been 
proposed as a novel biomarker source for various 
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types of cancers. To date, specific cancer markers 
have been detected in microvesicles isolated from 
peripheral  blood  of  colorectal  and  oral  cancer 
patients.  Unfortunately,  these  markers  were 
not consistently detected in early stage cancers. 
The  insufficient  early  stage  cancer  biomarker 
detection  in  microvesicles  may  result  from  the 
early tumor’s isolation from the circulation, which 
limits  the  passive  diffusion  of  microvesicles  into 
the  blood.  Also  complicating  detection  is  the 
further dilution of the tumor-derived microvesicles 
by  the  natural  shedding  of  microvesicles  by  all 
the cells that are in direct contact with the blood. 
Moreover,  complement-mediated  microvesicle 
formation, which constitutes a major mechanism 
for  microvesicle  release,  is  significantly  inhibited 
in tumor cells due to up-regulation of complement 
regulatory proteins upon malignant transformation. 
Although  saliva  is  currently  not  a  mainstream 
diagnostic body fluid, recent studies have shown 
that  genetic  analysis  of  various  components  of 
saliva,  such  as  microvesicles  have  the  ability  to 
discriminate and efficiently detect certain disease. 
Ideally, molecular characterization of microvesicles 
would  allow  a  non-invasive  sample  source  for 
early disease diagnosis, prognosis, as well as for 
monitoring treatment strategy and efficacy. Tumor-
derived  microvesicles  remain  an  enticing  source 
of biomarkers for tumor detection, prognosis and 
therapy monitoring. However, their role in cancer 
testing  will  require  new  methods  of  peripheral 
blood and saliva enrichment.
In summary, microvesicles are multifunctional 
entities that appear to play an active role in many 
significant biological processes such as regulation 
of  immune  response,  antigen  presentation, 
transfer  of  bioactive  molecules  between  cells 
and  tissues,  and  transfer  of  viruses  and  prions. 
Further investigations into cellular and molecular 
mechanisms of microvesicle biogenesis and function 
are needed to increase their efficacy as therapeutic 
tools. New and more efficient means of nucleic acid 
profiling of tumor microvesicles have the potential 
to be useful as biomarkers for screening and biopsy 
profiling.  Although,  microvesicles  can  be  easily 
identified by their size and physical characteristics 
from  biological  fluids  for  diagnostic  purposes, 
further research and proper validation is needed in 
order for them to be useful in the clinical setting.